Medications can help to slow the progression of interstitial lung disease, but many patients never regain the full use of their lungs, according to Mayo Clinic. Lung scarring due to interstitial lung disease is generally permanent, and treatment does not always stop the progression of the disease.
Interstitial lung disease is a disease that causes inflammation to the deep tissue within the lungs, eventually resulting in damage, as noted by the National Institutes of Health's Medline Plus. Interstitial lung disease can develop for unknown reasons, but may also be caused by radiation treatment
Symptoms of interstitial lung disease include dry coughs and shortness of breath, explains MedicineNet. Once the disease becomes advanced enough, fingers may become clubbed and the heart enlarged.
Ground glass opacification is a radiology term that refers to a hazy area of increased attenuation in the lung on an x-ray, explain Radiopaedia.org medical experts. Interstitial lung disease describes a large group of lung disorders which cause progressive scarring of lung tissue, according to Mayo
The prognosis for fungus in the lungs, or pulmonary aspergilloma, is positive in many cases. The condition rarely requires treatment, but if it leads to severe and potentially fatal bleeding, surgery may be necessary. Surgery may cause complications that significantly affect the prognosis, according
According to the American Cancer Society, the observed 5-year survival rate for patients who are diagnosed with stage II lung cancer is around 30 percent. Depending on the location and other qualities of the primary tumor, stage II lung cancer can be divided between types IIA and IIB. Survival rates
The American Cancer Society lists the 5-year survival rate for stage IV non-small-cell lung cancer as about one percent; stage IV small-cell lung cancer 5-year survival rates are at two percent. Mesothelioma has a 5-year survival rate of five to ten percent.
The prognosis for a blood clot in the lung depends on the size and location of the clot and how quickly treatment for the clot is initiated, according to eMedicineHealth. The bigger the blood vessel being blocked and the larger the clot, the worse the prognosis.
Around 30 percent of patients diagnosed with lung cancer have already reached stage 3, and their prognosis varies according to multiple factors, according to Dr. Lynne Eldridge, writing for About.com. The median survival time for stage 3a non-small cell cancer is 15 months, and stage 3b patients hav
The prognosis for lung sarcoma is mixed, with an average five-year survival rate of 50 percent, according to the American Cancer Society. Early diagnosis improves the survival rate to up to 83 percent if the cancer is discovered early and is localized.